MMP9 and lung adenocarcinoma: In lung adenocarcinoma (LUAD), RGCC stimulates epithelial-mesenchymal transition (EMT), enhances cell migration and invasion, and reduces MMP-2 and MMP-9 protein activity and expression 79.